N74 Female pelvic inflammatory disorders in diseases classified elsewhere - analogs
| Description «N74 Female pelvic inflammatory disorders in diseases classified elsewhere» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 40% Compare N70-N77 Inflammatory diseases of female pelvic organs
- 40% Compare N73 Other female pelvic inflammatory diseases
- 40% Compare N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere
- 40% Compare N73.9 Female pelvic inflammatory disease, unspecified
- 40% Compare N73.8 Other specified female pelvic inflammatory diseases
- 32% Compare N85 Other noninflammatory disorders of uterus, except cervix
- 32% Compare N88.8 Other specified noninflammatory disorders of cervix uteri
- 32% Compare N72 Inflammatory disease of cervix uteri
- 32% Compare N88.9 Noninflammatory disorder of cervix uteri, unspecified
- 32% Compare N88 Other noninflammatory disorders of cervix uteri
- 32% Compare N71.1 Chronic inflammatory disease of uterus
- 32% Compare N74.1 Female tuberculous pelvic inflammatory disease (A18.1+)
- 32% Compare N71 Inflammatory disease of uterus, except cervix
- 27% Compare N74.2 Female syphilitic pelvic inflammatory disease (A51.4+, A52.7+)
- 27% Compare N71.0 Acute inflammatory disease of uterus
- 27% Compare N71.9 Inflammatory disease of uterus, unspecified
- 27% Compare N74.0 Tuberculous infection of cervix uteri (A18.1+)
- 23% Compare N74.3 Female gonococcal pelvic inflammatory disease (A54.2+)
- 20% Compare N70 Salpingitis and oophoritis
- 20% Compare N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
- 18% Compare N70.1 Chronic salpingitis and oophoritis
- 18% Compare N70.0 Acute salpingitis and oophoritis
- 16% Compare N95.2 Postmenopausal atrophic vaginitis
- 16% Compare N73.5 Female pelvic peritonitis, unspecified
- 15% Compare N73.1 Chronic parametritis and pelvic cellulitis
- 15% Compare A59.0 Urogenital trichomoniasis
- 15% Compare N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere
- 13% Compare N73.4 Female chronic pelvic peritonitis
- 13% Compare A54.2 Gonococcal pelviperitonitis and other gonococcal genitourinary infections
- 11% Compare B37.3 Candidiasis of vulva and vagina (N77.1*)
- 10% Compare N11.8 Other chronic tubulo-interstitial nephritis
- 10% Compare M05.3 Rheumatoid arthritis with involvement of other organs and systems
- 10% Compare M13.0 Polyarthritis, unspecified
- 10% Compare N11.9 Chronic tubulo-interstitial nephritis, unspecified
- 10% Compare M06.8 Other specified rheumatoid arthritis
- 10% Compare M06.0 Seronegative rheumatoid arthritis
- 10% Compare M05.8 Other seropositive rheumatoid arthritis
- 10% Compare J22 Unspecified acute lower respiratory infection
- 10% Compare M06 Other rheumatoid arthritis
- 10% Compare G61 Inflammatory polyneuropathy
- 10% Compare M05 Seropositive rheumatoid arthritis
- 10% Compare U07.1 COVID-19, virus identified
- 10% Compare N41.1 Chronic prostatitis
- 10% Compare N10 Acute tubulo-interstitial nephritis
- 10% Compare M06.2 Rheumatoid bursitis
- 10% Compare G61.8 Other inflammatory polyneuropathies
- 10% Compare H66 Suppurative and unspecified otitis media
- 10% Compare J90 Pleural effusion, not elsewhere classified
- 10% Compare K75.9 Inflammatory liver disease, unspecified
- 10% Compare M06.4 Inflammatory polyarthropathy
Learn more about the selection of analogues
▶
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.